Inversely, in the liver samples from patients with cancer, HSD17B13 expression was decreased, showing IHC scores of 29.52 ± 3.35 (Figure 1A), which were consistent with previous reports from patients with HCC [26]. Here, HSD17B13 is linked to hepatocellular carcinoma.